📰New & Featured | 🧬A new Cell study identified receptor #Or5v1/#Olfr110, senses #oxylipin signals and boosts liver fat burning and glucose control.
❓Could targeting such receptors become a new strategy against metabolic disease?👇
#obesity #antiobesity

This review highlights the links between #obesity and #aging, noting shared hallmarks like #inflammation, #telomere loss, and #MitochondrialDysfunction, and emphasizes the potential of #AntiObesity therapies to combat age‑related diseases.

#OpenAccess: doi.org/10.1016/j.ge...

New Research Reveals That This Popular Spice Has Powerful Anti-Obesity Effects Human clinical trials reveal that black cumin has anti-obesity and heart-protective effects. Nigella sativa (black cumin) is best known as a flavorful spice used in dishes like korma and paneer, but it...

New Research Reveals That This Popular Spice Has Powerful Anti-Obesity Effects #Science #HealthandMedicine #Nutrition #AntiObesity #HealthResearch #NutritionScience

Green-synthesized chromium oxide nanoparticles using pomegranate husk extract: Multifunctional bioactivity in antioxidant potential, lipase and amylase inhibition, and cytotoxicity Malnutrition is a growing global health concern that contributes to obesity. This study presents the green synthesis of chromium oxide nanoparticles (Cr₂O₃ NPs) using pomegranate husk aqueous extract…

This study presents the #GreenSynthesis of chromium oxide #nanoparticles (Cr₂O₃ NPs) using pomegranate husk aqueous extract and demonstrate its potential #Antioxidant and #AntiObesity effects.

Click here to read this Green Processing and Synthesis #OpenAccess:

Sun Pharma, Lupin push for affordable anti-obesity pills in India - Mint Investing.com-- India’s Sun Pharmaceutical Industries (NSE:SUN) and Lupin Ltd (NSE:LUPN) are seeking regulatory approval to develop affordable anti-obesity pills as the country faces a mounting obesity crisis, Mint reported on Monday, citing documents and a person familiar with the matter. The Drugs Controller General of India (DCGI) has cleared Sun Pharma to conduct a large-scale Phase III trial for its semaglutide tablets, while Lupin has received approval to begin a bioequivalence study to show its generic version performs similarly to the original, Mint said. Currently, anti-obesity drugs such as Novo Nordisk’s (CSE:NOVOb) Wegovy and Eli Lilly’s (NYSE:LLY) Mounjaro remain costly and largely limited to injections, reducing accessibility for Indian patients. A Lancet study has projected India could have 450 million overweight and obese adults by 2050. Experts cited by Mint said generics could bring costs down but warned against misuse, stressing the need for strict medical supervision and regulatory safeguards. With LLY making headlines, savvy investors are asking: Is it truly valued fairly? In a market full of overpriced darlings, identifying true value can be challenging. InvestingPro's advanced AI algorithms have analyzed LLY alongside thousands of other stocks to uncover hidden gems. These undervalued stocks, potentially including LLY, could offer substantial returns as the market corrects. In 2025 alone, our AI identified several undervalued stocks that later surged by 50% or more. Is LLY poised for similar growth? Don't miss the opportunity to find out.

Click Subscribe #SunPharma #Lupin #AffordableHealthcare #AntiObesity #ObesityCrisis

Anti-Obesity Drugs Market Size, Growth Report 2035 - News and Updates Anti-Obesity Drugs Market accounted for registering a CAGR of 9.0% during the forecast period and is estimated to reach USD 30.81 billion by 2035. - News and Updates

Anti-Obesity Drugs Market
⚖️ Rising demand for #AntiObesity drugs fueling global growth 🌍🔥 #WeightLoss #HealthcareMarket #Pharma

www.marketresearchfuture.com/press-releas...

Should Everyone Be Taking Ozempic? Doctors Say More People Could Benefit Anti-obesity drugs are showing promise for ever-expanding list of diseases

Should everyone be taking drugs like #Ozempic? #Drugs in the #GLP1-category show promise for a growing list of #health conditions.
#Antiobesity drugs are showing promise for ever-expanding list of #diseases.
www.wsj.com/health/pharm... via @WSJ

💡Revolutionizing the intersection of bariatric surgery and anti-obesity medications
➡️https://buff.ly/4ga0i23

Drs Simon Laplante & Omar M. Ghane look at a recent BJS editorial.

@bjsurgery.bsky.social #BariatricSurgery #AntiObesity

#46shines #Medicare #Medicaid #AntiObesity #Weightloss #Ozempic

Bariatric surgery is more cost-effective than GLP-1 drugs April 29, 2024

Today in #Employer Coverage: Bariatric Surgery is more cost-effective than #GLP-1 #antiobesity medications.
open.substack.com/pub/employer...

@MarionNestle: How can @Beyonce take a $50mil @Pepsi contract while working for @MichelleObama's #antiobesity initiative? #HunterTischHealth